Cue Biopharma (CUE) has disclosed a new risk, in the Share Price & Shareholder Rights category. Cue Biopharma faces a significant risk ...

Kaixin announced the receipt of a notification letter dated November 12, 2024 from the Hearing Panel of the Nasdaq Stock Market, notifying Kaixin that the Company has regained compliance with the ...

G-P Gia™ instantly provides context-specific HR and legal guidance and actionable documents in over 50 countries and all 50 U ...

Diana M. Eng and Susan Kuruvilla of Blank Rome LLP discuss Guidance issued by the New York State Department of Financial ...

Without a delay, “millions of small business owners become accidentally and unknowingly delinquent in their compliance,” reads the letter, signed by CEO Barry Melancon, CPA, CGMA.

On October 7, 2024, the Securities and Exchange Commission (SEC) approved a rule change proposed by The Nasdaq Stock Market LLC that impacts ...

2. 30,0001-, The Id. CIT erred in law as well as on the facts in confirming the imposition of penalty u/s 272A (1) (C) of Rs. 30,000/-. The penalty so imposed being totally contrary to the provisions ...

Any change in the party of the White House occupant poses potential risk for business, but a return to power of the ...

Globalization Partners LLC, which does business as G-P, today announced a large language model-based artificial intelligence ...

--(BUSINESS ... it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with requirements ...

Covered entities (CEs) and business associates (BAs) may receive a “discount” for having recognized security practices (RSPs) ...

Business owners have 15 days to respond to FDA warning letters. Warning letters often are not issued ... Both firms received a Form FDA 483a, detailing their serious compliance lapses. Located in ...